CAN
PBE icon

Cetera Advisor Networks’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Cetera Advisor Networks’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$455K Sell
7,036
-2,025
-22% -$132K ﹤0.01% 1993
2023
Q4 		$597K Sell
9,061
-7,960
-47% -$463K ﹤0.01% 1732
2023
Q3 		$971K Sell
17,021
-867
-5% -$52.9K 0.01% 1304
2023
Q2 		$1.1M Sell
17,888
-725
-4% -$45.2K 0.01% 1207
2023
Q1 		$1.17M Sell
18,613
-885
-5% -$57K 0.01% 1140
2022
Q4 		$1.24M Buy
19,498
+140
+0.7% +$8.88K 0.01% 1061
2022
Q3 		$1.14M Sell
19,358
-1,037
-5% -$63.9K 0.01% 819
2022
Q2 		$1.18M Sell
20,395
-6,209
-23% -$358K 0.02% 806
2022
Q1 		$1.65M Buy
26,604
+5,019
+23% +$306K 0.02% 691
2021
Q4 		$1.54M Buy
+21,585
New +$1.56M 0.02% 706
2020
Q3 		– Sell
-1,994
Closed -$116K – 2483
2020
Q2 		$116K Buy
+1,994
New +$109K ﹤0.01% 1412
2016
Q2 		– Sell
-5,226
Closed -$204K – 858
2016
Q1 		$204K Sell
5,226
-428
-8% -$16.6K 0.01% 745
2015
Q4 		$283K Sell
5,654
-50
-0.9% -$2.47K 0.02% 626
2015
Q3 		$264K Buy
5,704
+374
+7% +$20.9K 0.02% 627
2015
Q2 		$297K Hold
5,330
– – 0.02% 627
2015
Q1 		$297K Sell
5,330
-1,451
-21% -$78.4K 0.02% 631
2014
Q4 		$339K Sell
6,781
-2,042
-23% -$99.9K 0.02% 558
2014
Q3 		$409K Buy
8,823
+1,302
+17% +$58.7K 0.03% 510
2014
Q2 		$327K Sell
7,521
-196
-3% -$7.94K 0.02% 593
2014
Q1 		$316K Buy
7,717
+2,240
+41% +$95.8K 0.02% 570
2013
Q4 		$201K Sell
5,477
-333
-6% -$11.9K 0.02% 694
2013
Q3 		$206K Buy
+5,810
New +$192K 0.02% 623

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Cetera Advisor Networks's PBE Position: Q1 2024 in Review

Cetera Advisor Networks reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 22% in Q1 2024, selling an estimated $132K and leaving 7,036 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

Cetera Advisor Networks first reported a position in PBE in Q3 2013 and has held it in 22 quarters since. The position peaked at $1.65M in Q1 2022. 102 funds tracked by Wall St. Rank hold PBE as of Q1 2024.

  • Cetera Advisor Networks held 7,036 shares of Invesco Biotechnology & Genome ETF worth $455K as of Q1 2024.
  • Cetera Advisor Networks sold 2,025 Invesco Biotechnology & Genome ETF shares in Q1 2024, an estimated $132K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1993 holding.
  • Cetera Advisor Networks first reported a position in Invesco Biotechnology & Genome ETF in Q3 2013 and has held it in 22 quarters since.
  • Cetera Advisor Networks's Invesco Biotechnology & Genome ETF position peaked at $1.65M in Q1 2022.
  • 102 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.